Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Cancer Research|March 5, 2003
CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigenRonald C Kennedy, Michael H Shearer, Allison M Watts, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2007
Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunityLaura A Payton, Jennifer D Lewis, Jennifer A Byrne, et al.
Lab on a Chip|January 8, 2025
Advances in microfluidic platforms for tumor cell phenotyping: from bench to bedsideRutwik Joshi, Hesaneh Ahmadi, Karl Gardner, et al.
Molecular Carcinogenesis|May 11, 2013
TPD52 represents a survival factor in ERBB2-amplified breast cancer cellsNuruliza Roslan, Ivan Bièche, Robert K Bright, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2002
SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patientsRobert K Bright, Eric T Kimchi, Michael H Shearer, et al.
Journal of Virology|November 6, 2009
Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phaseDevin B Lowe, Michael H Shearer, Cynthia A Jumper, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2009
Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSFJennifer D Lewis, Laura A Sullivan, Jennifer A Byrne, et al.
Cancer Immunology, Immunotherapy : CII|May 25, 2004
Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunityRonald C Kennedy, Michael H Shearer, Devin B Lowe, et al.
Pageof 4